The Fear porn started early in 2022.. I was asked a

New Post Public Reply Private Reply Replies (0) Message Board
martymech
291
The Fear porn started early in 2022.. I was asked a question about RS and this is a list of reasons why that isn't going to happen in my view. Thought I would save it to this board so that when it gets deleted there is a bit of a record. Cheers.




Great question and that didn't take too long for that RS question to come up lol. I have no concerns about an RS and I see that misguided notion has been suggested here just yesterday. ( Also noteworthy is that he stated that he/she just sold his/her position in EGOC) He was wrong in his/her assessment of that new rules deadline not being met in time to stay on the OTC back in September and he/she is wrong about this new fear porn! Here are just some of the reasons that I do not subscribe to that flawed thinking that has been suggested here yesterday. *** Special note these are my opinions based upon my research of Historical documents that are available for all to review. Each should do their own DD!

1) Because "Curios" warned all of us yesterday about his believing that they would reverse split. Noteworthy is his post count to date and also that he stated he sold his position or sold his shares of EGOC yesterday. Motive might be in question!

2) If you go back and read some of the articles concerning who's who in the network of companies supporting the EGOC up listing to Nasdaq you will find statements that were publicly made that said all of the companies or some of them (paraphrasing from memory) were in their own rights worthy and presently able to list with their current situation .. In other words they apparently already meet the nasdaq listing requirements in their own right. EGOC apparently has mega support from the government and companies in china to get the uplisting done. Their words not mine! Again working off of memory and generalizing!

3)I see the current share structure to be perfect for the "dual or secondary listing" that they indicated in press releases last summer as their somewhat immediate and short term goals along with their 5 year revenues and net worth predictions that were hugely impressive. I believe that a reverse split (that is being promoted here by a single person that clearly stated that he sold his shares yesterday) is not in the companies plan going forward. They probably picked EGOC as their vehicle because the share structure is perfect to either split it in half where half are traded here on our US stock exchange and the other half traded on the Hong Kong exchange. No need to add or subtract shares in order to achieve their stated goals of uplisting to Nasdaq and returning to the Hong Kong Exchange as they stated in their press release!

4)EGOC recently announced that after the name change ticker change is completed they will then vote in a new guy to the board. One of his primary stated objectives is to increase share holder value. I think that it is safe to say that a RS is not something that he would want to even think about as that would not be in the best interest of those in China that recently became share holders and the share holders in the US. Nuff said there!

5) If you remember a couple of months ago there were some translated articles that came out from China where EGOC/ Pang Bo Group were giving out "original shares" of EGOC to their people and selling them EGOC shares promoting their stated uplisting goals and also returning to the Hong Kong Exchange. They apparently have no intentions of doing anything hoaky with share splitting as a result of their actions and statements to date! They are the ones that know what their EGOC is going to entail and they already know that they will qualify for Nasdaq and the Hong kong exchange. Very confident indeed!

6)One person recently suggested this split scenario after selling his position in EGOC. Normally when one sells a stock they don't go out of their way to poooo pooooo on said stock unless their intention is to get people to sell so he/she can buy back in. Normal investors just move on to their next investment without trying to destroy or create confusion on their old stock comment boards and their investors. So I believe this is just an effort to get back in cheaper knowing that EGOC is going to move up in a big way. Just a flipper in my opinion! Does that kind of behavior happen? Yes and quite often. Sadly.

7) That person bases his opinions of RS solely on not being able to find financials or other information or floating financials from as yet unproven sites or companies that may or may not have anything to do with EGOC. and then saying that they would have to do a RS in order to achieve the requirements of that uplisting to Nasdaq etc. Previous articles concerning the high rolling companies with high financial support would indicate that poster is completely and utterly wrong in his beliefs once again! He/She has no idea what the new companies assets are, income is, what companies will be under the EGOC or ECEN ticker symbol yet ..etc etc. Those companies are private companies from what I have seen and as such their financials are not typically put out for all to see. There is no mystery to that fact and yet the chief reasons for his/her flawed assessments are things that he can not know for sure.. YET.

Like I said the information that has come out of China concerning company statements and their actions along with the companies that are backing EGOC's listing are quite extensive and impressive and I don't believe that Pang Bo Group and affiliated companies would stick their necks out and make such statements if they didn't already meet the requirements to uplist and also do a secondary or dual listing on the Hong Kong Exchange!

I am sure that I am leaving out a lot of reasons but so far I have a pretty good batting average with this Reverse merger and their progress and what they intend to do going forward.

As usual it is up to each individual investor to weigh the upside and downside here. I see huge upside and I also believe that the current pps is way under valued given all of the available information to date. I believe that the current pps is very very low and the catalysts that are coming down the road at 90 miles per hour is going to make EGOC probably one of the biggest gainers in the market for 2022! I am confident in EGOC going forward. JMO


Energy 1 Corporation (EGOC) Stock Research Links

EGOC Board Company Profile Buy Rating Time & Sales News Filings Financials
What I post is my opinions and thoughts based on my research. Please do your own DD before buying or selling any stock. I am just as capable as the next guy in making good or bad investment choices! We win a few, we lose a few. That is the nature of the game!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 3

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
Cyngn: A Deep Dive into Its Robust 24-Patent Portfolio

Updated Category News Views 4

Cyngn's Growing Patent Portfolio: A Robust Defense Ah, Cyngn Inc., the hotshot in AI-powered autonomous vehicle tech, is flexing its muscles with a solid 24-patent stash. We're talking about a company that's not messing around, racking these up since they decided to dive head-first into solving the brain-busting problems of the industrial sector. Their strategy? Build and...

Continue Reading
New Concierge Pediatric Care at Weill Cornell Launches

Updated Category News Views 3

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 3

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 6

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading
BellRing Brands Faces Legal Probe; Fiduciary Duties Questioned

Updated Category News Views 1

What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...

Continue Reading
S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Updated Category News Views 5

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Continue Reading
TrailBlazer Magazine Snags a Tribune for In-House Design

Updated Category News Views 4

Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...

Continue Reading
MMRO Achieves URAC AI Accreditation, Ensures Compliance

Updated Category News Views 4

A Milestone in Healthcare AI: MMRO's New Accreditation When AI in healthcare gets an official nod from the big guys like URAC, it's a significant moment. We're talking about Managed Medical Review Organization, Inc. (MMRO), a firm that's just earned the URAC Artificial Intelligence in Health Care Accreditation. Now, this isn't just some rubber stamp; it's a testament to...

Continue Reading
Dimerix Locks Down A$34M Loan: No Shareholder Dilution

Updated Category News Views 2

Dimerix Grabs Non-Dilutive Funds amid Kidney Trials Here we go with Dimerix's latest move, folks. They roped in A$34 million through a cozy get-together with lenders from Australia and the U.S. What's the kicker? This cash won't touch shareholder equity. So, breathe easy, investors. It's a rare feat to pull off non-dilutive funds these days, especially in the biopharma...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming the Narcolepsy Market: Innovations Ahead

Updated Category News Views 166

The Evolving Landscape of the Narcolepsy Market The narcolepsy market is undergoing significant changes as it shifts from merely managing symptoms to developing targeted therapies that tackle the root causes of the disorder. Traditionally, treatments focused on alleviating symptoms, but advancements now emphasize addressing the underlying neurochemical issues, primarily...

Continue Reading
UBS Analysts Share Insights on China Stocks Strategies

Updated Category News Views 242

UBS Analysts Offer Insights on China's Equity Market In a recent discussion, UBS strategists have expressed a level of caution regarding China's equity market as they look into the evolving landscape of 2025. It's noted that local A-share investors appear hesitant to seize buying opportunities, influenced by a myriad of factors that create uncertainty in the market....

Continue Reading
Palisade Bio's Special Meeting Cancellation: What You Need to Know

Updated Category News Views 133

Palisade Bio Cancels Special Meeting of Stockholders Palisade Bio, Inc. (Nasdaq: PALI) is a clinical-stage biopharmaceutical company making strides in developing innovative treatments for autoimmune, inflammatory, and fibrotic diseases. Recently, the company announced an important decision regarding its special meeting of stockholders. The special meeting, originally...

Continue Reading
Vivendi Reports Impressive 4.5% Revenue Growth in 2024

Updated Category News Views 123

Remarkable Revenue Growth for Vivendi Vivendi has announced an impressive increase in its revenues for the first nine months of 2024, emphasizing strong growth across its core business sectors. The company reported a revenue increase of 4.5% at constant currency and perimeter, compared to the same period in the previous year. This growth showcases the resilience and...

Continue Reading
Revolution in Home Renovation Arrives with Spray-Net Franchise

Updated Category News Views 226

Fresh Approach to Home Makeovers Home remodeling isn’t just about slapping on a new coat of paint anymore. In February 2026, Spray-Net is gearing up to launch in Allen, Texas, shaking things up in the renovation game. This venture represents a leap forward—not only for franchise growth but for homeowners who are sick and tired of traditional, drawn-out renovations....

Continue Reading